as on November 28, 2025 at 9:37 pm IST
Day's Low
Day's High
1.29%
Downside
1.29%
Upside
52 Week's Low
52 Week's High
61.80%
Downside
5.65%
Upside
Check Regenxbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$671.3M
EPS (TTM)
-3.2558
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.46
Industry PE ratio
-0.4356168831168831
PEG Ratio
0.26
EBITDA
-139.2M
Revenue (TTM)
161.3M
Profit Margin
-110.29%
Return On Equity TTM
-76.88%
Track how Regenxbio Inc P/E has moved over time to understand its valuation trends.
Regenxbio Inc in the last 5 years
Lowest (-14.61x)
March 31, 2021
Today (-2.46x)
November 28, 2025
Industry (-0.44x)
November 28, 2025
Highest (19.14x)
September 30, 2022
Today’s Price to Earnings Ratio: -2.46x
Compare market cap, revenue, PE, and other key metrics of Regenxbio Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $671.3M | -64.21% | -2.46 | -110.29% | |
| BUY | $43.6B | 413.84% | -16.34 | -264.83% | |
| BUY | $58.8B | 242.77% | 1435.87 | 1.36% | |
| BUY | $110.8B | 90.63% | 30.22 | 31.35% | |
| BUY | $83.2B | 52.63% | 18.87 | 32.13% |
The Regenxbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Regenxbio Inc investment value today
Current value as on today
₹1,37,544
Returns
₹37,544
(+37.54%)
Returns from Regenxbio Inc Stock
₹31,668 (+31.67%)
Dollar Returns*
₹5,876 (+5.88%)
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Regenxbio Inc. Average target price of $29.55
Get share price movements and forecasts by analysts on Regenxbio Inc.
What analysts predicted
55.4%UPSIDE
Target Price
$29.55
Current Price
$13.18
Analyzed by
18 Analysts
Target
$29.55
Regenxbio Inc target price $29.55, a slight upside of 55.4% compared to current price of $13.18. According to 18 analysts rating.
Search interest for Regenxbio Inc Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -70.87M → -61.94M (in $), with an average increase of 14.4% per quarter
Price Rise
![]()
In the last 7 days, RGNX stock has moved up by 12.4%
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 21.35M → 29.73M (in $), with an average increase of 28.2% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1006.1% return, outperforming this stock by 1047.7%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 169.5% return, outperforming this stock by 137.0%
| Organisation | Regenxbio Inc |
| Headquarters | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
| Industry | Health Technology |
| CEO | Mr. Curran M. Simpson M.S. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Mitchell Chan M.B.A. | Executive VP & CFO |
Dr. Olivier Danos Ph.D. | Executive VP & Chief Scientific Officer |
Dr. Stephen Pakola M.D. | Executive VP & Chief Medical Officer |
Mr. Craig Malzahn | Executive VP of Product Development & CTO |
Dr. Ram Palanki Pharm.D. | Executive VP & Chief Commercial Officer |
Mr. Curran M. Simpson M.S. | President, CEO & Director |
Mr. Patrick J. Christmas II, J.D. | Executive VP & Chief Strategy and Legal Officer |
Ms. Shiva G. Fritsch | Chief Communications & People Officer |
Ms. Sarah Thomas | Senior Vice President of Quality |
Dr. Jahannaz Dastgir D.O. | Clinical Development Lead |
Regenxbio Inc share price today is $13.18 as on . Regenxbio Inc share today touched a day high of $13.35 and a low of $13.01.
Regenxbio Inc share touched a 52 week high of $13.93 on and a 52 week low of $5.04 on . Regenxbio Inc stock price today i.e. is trending at $13.18,which is 5.35% down from its 52 week high and 161.77% up from its 52 week low.
Regenxbio Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Regenxbio Inc (RGNX) shares with as little as ₹89.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹894.36 in Regenxbio Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Regenxbio Inc share’s latest price of $13.18 as on November 28, 2025 at 9:37 pm IST, you will get 0.7587 shares of Regenxbio Inc. Learn more about
fractional shares .
Regenxbio Inc stock has given -64.21% share price returns and 20.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?